Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vancomycin-resistant enterococci in pediatric hematology: don't panic!]

G Barbé1, C Ploton, C Pondarré

  • 1Laboratoire de Bactériologie, Faculté de Pharmacie (UPRES-EA 1655), Hôpital Debrousse, Lyon, France.

Pathologie-Biologie
|October 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing acute toxicity profiles of HLA-identical hematopoietic stem cell transplantation in pediatric patients with sickle cell anemia: A comprehensive analysis on behalf of the SFGM-TC.

American journal of hematology·2024
Same author

[Assessment of the effect of the COVID-19 health crisis on the aerobic capacities of healthy patients. Analysis of the effort tests of the patients of the sports medicine services of the Angers UHC and the Cholet HC between May 2018 and May 2021].

Science & sports·2022
Same author

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease.

Blood·2020
Same author

[Cerebral vasculopathy in children with sickle cell disease: Key issues and the latest data].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017
Same author

Phenotypic changes contributing to Enterobacter gergoviae biocide resistance.

Letters in applied microbiology·2015
Same author

[Information for parents of children with sickle cell trait detected by neonatal screening: A 10-year experience].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2015
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

Immunocompromised children carrying vancomycin-resistant enterococci (VRE) may not require eradication treatment. Strict hygiene measures are crucial, as VRE colonization did not lead to bacteremia in this study.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pediatric Oncology

Context:

  • Investigating vancomycin-resistant enterococci (VRE) colonization in immunocompromised children undergoing chemotherapy or bone-marrow transplantation (BMT).
  • Evaluating decontamination protocols including amikacin and vancomycin mouth rinses.
  • Monitoring VRE carriage in a cohort of 230 pediatric patients over three years.

Purpose:

  • To determine if treatment is necessary for immunocompromised children colonized with VRE.
  • To assess the risk of VRE bacteremia in this patient population.
  • To evaluate the efficacy of gut decontamination strategies.

Summary:

  • Four pediatric patients with chemotherapy/BMT were identified as VRE carriers.
  • Fecal VRE carriage was persistent in one patient, with failed eradication attempts.

Related Experiment Videos

  • No VRE bacteremia occurred in any of the VRE-colonized patients.

    • Impact:

    • Suggests that VRE eradication may not be necessary in immunocompromised pediatric patients.
    • Highlights the importance of strict adherence to hygienic measures to prevent VRE complications.
    • Informs clinical decision-making regarding VRE management in vulnerable pediatric populations.